Vericel Corp (NASDAQ: VCEL)’s stock price has plunge by 0.67relation to previous closing price of 41.50. Nevertheless, the company has seen a -5.43% plunge in its stock price over the last five trading sessions. seekingalpha.com reported 2025-06-12 that Vericel’s valuation has moderated after a 20% share price drop, prompting a shift from sell to neutral. MACI remains the company’s primary growth engine, with strong sales momentum and successful surgeon training on new indications. The stock enjoys bullish analyst firm support and Vericel’s balance sheet is in a strong position.
Is It Worth Investing in Vericel Corp (NASDAQ: VCEL) Right Now?
The price-to-earnings ratio for Vericel Corp (NASDAQ: VCEL) is above average at 1057.72x, Company’s 36-month beta value is 1.34.Analysts have differing opinions on the stock, with 7 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for VCEL is 49.79M, and currently, short sellers hold a 9.28% ratio of that floaft. The average trading volume of VCEL on June 19, 2025 was 513.97K shares.
VCEL’s Market Performance
VCEL stock saw a decrease of -5.43% in the past week, with a monthly decline of -1.79% and a quarterly a decrease of -11.91%. The volatility ratio for the week is 1.48%, and the volatility levels for the last 30 days are 2.56% for Vericel Corp (VCEL). The simple moving average for the past 20 days is -1.21% for VCEL’s stock, with a -13.94% simple moving average for the past 200 days.
Analysts’ Opinion of VCEL
Many brokerage firms have already submitted their reports for VCEL stocks, with Canaccord Genuity repeating the rating for VCEL by listing it as a “Buy.” The predicted price for VCEL in the upcoming period, according to Canaccord Genuity is $57 based on the research report published on August 09, 2024 of the previous year 2024.
TD Cowen, on the other hand, stated in their research note that they expect to see VCEL reach a price target of $55. The rating they have provided for VCEL stocks is “Buy” according to the report published on June 20th, 2024.
Truist gave a rating of “Buy” to VCEL, setting the target price at $51 in the report published on January 25th of the previous year.
VCEL Trading at 0.84% from the 50-Day Moving Average
After a stumble in the market that brought VCEL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.68% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VCEL starting from Hopper Jonathan Mark, who sale 10,000 shares at the price of $40.09 back on Jun 02 ’25. After this action, Hopper Jonathan Mark now owns 66,237 shares of Vericel Corp, valued at $400,900 using the latest closing price.
Hopper Jonathan Mark, the Officer of Vericel Corp, proposed sale 10,000 shares at $41.13 during a trade that took place back on Jun 02 ’25, which means that Hopper Jonathan Mark is holding shares at $411,300 based on the most recent closing price.
Stock Fundamentals for VCEL
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.73 for the gross margin
The net margin for Vericel Corp stands at 0.01. The total capital return value is set at -0.01. Equity return is now at value 1.13, with 0.76 for asset returns.
Based on Vericel Corp (VCEL), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at 0.58. The debt to equity ratio resting at 0.33. The interest coverage ratio of the stock is -4.57.
Currently, EBITDA for the company is 16.63 million with net debt to EBITDA at 2.41. When we switch over and look at the enterprise to sales, we see a ratio of 8.92. The receivables turnover for the company is 4.51for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.01.
Conclusion
In a nutshell, Vericel Corp (VCEL) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
